The 1-Year Safety and Efficacy Outcomes of Magmaris, Novel Magnesium Bioresorbable Vascular Scaffolds in Diabetes Mellitus Patients with Acute Coronary Syndrome.
Adrian WłodarczakMagdalena ŁanochaMarek SzudrowiczMateusz BaryckiAlicja GosiewskaJan Jakub KulczyckiMaciej LesiakAdrian DoroszkoPiotr RolaPublished in: Journal of clinical medicine (2021)
The early 1-year-outcome of magnesium bioresorbable scaffold (Magmaris) seems to be favorable and suggests that this novel BRS is safe and effective in subjects with NSTE-ACS and co-existing DM.